Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-16-016941
Filing Date
2016-06-06
Accepted
2016-06-06 13:20:52
Documents
2
Period of Report
2016-06-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_146523363876501.html 4  
1 FORM 4 wf-form4_146523363876501.xml 4 3957
2 HASTINGS POA hastingspoa.htm EX-24 3697
  Complete submission text file 0001628280-16-016941.txt   8997
Mailing Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548
Business Address 101 HUDSON STREET SUITE 3610 JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 50 AVENUE GENERAL DE GAULLE BRUXELLES C9 9999999999
Business Address
HASTINGS DAVID C (Reporting) CIK: 0001237401 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 161698107